St Louis, Missouri
Colorectal cancer clinical trials in St Louis, MO
63 colorectal cancer studies are recruiting participants at sites in St Louis as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
St Louis at a glance
- 63 studies are recruiting at a site in St Louis.
- By phase: Phase 1 (16), Phase 1/2 (14), Phase 2 (4), Phase 2/3 (2), Phase 3 (7), Phase 4 (1), No phase (8), Observational (11). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (40), university, hospital or other (21), government (2).
- Most recent update to one of these records: November 12, 2026.
Studies recruiting in St Louis
Basic details from each study's public record (the 30 most recently updated of 63). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Study site
- Washington University Medicine
- Registry record
- NCT06270706 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Washington University
- Registry record
- NCT07659795 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Washington University School of Medicine
- Registry record
- NCT07020221 · updated
The Vanguard Study: Testing a New Way to Screen for Cancer
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Washington University School of Medicine
- Registry record
- NCT06995898 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
- Registry record
- NCT07018869 · updated
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- Missouri Baptist Medical Center
- Registry record
- NCT03998202 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Study site
- Washington University School of Medicine
- Registry record
- NCT07446322 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study sites
- Mercy Hospital Saint Louis · Mercy Hospital South · Missouri Baptist Medical Center
- Registry record
- NCT06418204 · updated
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Washington University
- Registry record
- NCT07114601 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Washington University School of Medicine in St. Louis
- Registry record
- NCT07213791 · updated
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
- Registry record
- NCT07283939 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Siteman Cancer Center
- Registry record
- NCT07397338 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Mercy Hospital Saint Louis · Mercy Hospital South · Missouri Baptist Medical Center
- Registry record
- NCT05673148 · updated
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sairopa B.V.
- Study site
- Washington University Medical Campus
- Registry record
- NCT05856981 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Washington University School Of Medicine
- Registry record
- NCT06662786 · updated
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Washington University School Of Medicine
- Registry record
- NCT06750094 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Mercy Hospital Saint Louis · Mercy Hospital South · Mercy Infusion Center - Chippewa
- Registry record
- NCT07143487 · updated
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Washington University School of Medicine in St. Louis
- Registry record
- NCT07416552 · updated
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Washington University Saint Louis
- Registry record
- NCT07702032 · updated
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Washington University School of Medicine at St Louis
- Registry record
- NCT03526835 · updated
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Washington University School of Medicine
- Registry record
- NCT07284849 · updated
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Inc
- Study site
- Washington University School of Medicine
- Registry record
- NCT07094204 · updated
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Saint Louis University
- Registry record
- NCT06710756 · updated
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Washington University
- Registry record
- NCT04981119 · updated
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Alterome Therapeutics, Inc.
- Registry record
- NCT06835569 · updated
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Study site
- Washington University
- Registry record
- NCT06973564 · updated
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Washington University School OF Medicine-Siteman Cancer Center
- Registry record
- NCT07221357 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in St Louis, MO on ClinicalTrials.gov.
Ask about studies near St Louis
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections